Related Experiment Videos

Toxicokinetics of the mycotoxin fumonisin B2 in rats

G S Shephard1, P G Thiel, E W Sydenham

  • 1Programme on Mycotoxins and Experimental Carcinogenesis, Medical Research Council, Tygerberg, South Africa.

Insights

Fumonisin B2 (FB2) is rapidly absorbed and eliminated in rats, with most of the toxin excreted unmetabolized in feces after administration. This study details FB2 toxicokinetics in rats.

Area of Science:

  • Mycology
  • Toxicology
  • Pharmacokinetics

Background:

  • Fumonisin B2 (FB2) is a mycotoxin produced by Fusarium moniliforme.
  • Understanding FB2 toxicokinetics is crucial for assessing its health risks.

Purpose of the Study:

  • To investigate the absorption, distribution, metabolism, and excretion (ADME) of Fumonisin B2 in male BD IX rats.
  • To determine the routes and rate of FB2 elimination from the body.

Main Methods:

  • Male BD IX rats were administered FB2 (7.5 mg/kg) via intraperitoneal injection or oral gavage.
  • Plasma FB2 levels were monitored over time.
  • Urinary and fecal excretion of FB2 was quantified over 72 hours.

Main Results:

  • FB2 was rapidly absorbed after intraperitoneal injection, with peak plasma levels at 20 minutes and a half-life of 26 minutes.
  • No detectable FB2 was found in plasma 24 hours after injection or 6 hours after gavage.
  • Approximately 82-84% of the administered dose was eliminated in feces, and 0.2-1.2% in urine, primarily unmetabolized.

Conclusions:

  • FB2 is rapidly absorbed and eliminated in rats, with fecal excretion being the primary route.
  • The toxin is excreted largely unmetabolized, suggesting limited systemic metabolism.

Related Concept Videos